SINGLE-AGENT OFATUMUMAB, A NOVEL CD20 MONOCLONAL ANTIBODY, RESULTS IN HIGH RESPONSE RATES IN PATIENTS WITH FLUDARABINE-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ALSO REFRACTORY TO ALEMTUZUMAB OR WITH BULKY LYMPHADENOPATHY

Osterborg, A (author)

Karolinska Institutet

Kipps, T (author)

Mayer, J (author)

show more...

Stilgenbauer, S (author)

Williams, CD (author)

Hellmann, A (author)

Robak, T (author)

Furman, R (author)

Hillmen, P (author)

Trneny, M (author)

Dyer, MJS (author)

Padmanabhan, S (author)

Piotrowska, M (author)

Kozak, T (author)

Chan, G (author)

Davis, R (author)

Losic, N (author)

Wilms, J (author)

Russell, C (author)

Wierda, WG (author)

show less...

 (creator_code:org_t)

2009

2009

English.

In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. - 0390-6078. ; 94, s. 200-200

Related links:

http://kipublication...

• Conference paper (other academic/artistic)